- Home
- BLFS vs LGIH Comparison
BLFS vs LGIH Comparison
Compare BLFS & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- LGIH
- Stock Information
- Founded
- BLFS 1987
- LGIH 2003
- Country
- BLFS United States
- LGIH United States
- Employees
- BLFS N/A
- LGIH N/A
- Industry
- BLFS Medical/Dental Instruments
- LGIH Homebuilding
- Sector
- BLFS Health Care
- LGIH Consumer Discretionary
- Exchange
- BLFS Nasdaq
- LGIH Nasdaq
- Market Cap
- BLFS 1.3B
- LGIH 1.1B
- IPO Year
- BLFS 1989
- LGIH 2013
- Fundamental
- Price
- BLFS $24.10
- LGIH $45.97
- Analyst Decision
- BLFS Strong Buy
- LGIH Hold
- Analyst Count
- BLFS 5
- LGIH 5
- Target Price
- BLFS $30.60
- LGIH $71.13
- AVG Volume (30 Days)
- BLFS 327.5K
- LGIH 390.8K
- Earning Date
- BLFS 11-06-2025
- LGIH 11-04-2025
- Dividend Yield
- BLFS N/A
- LGIH N/A
- EPS Growth
- BLFS N/A
- LGIH N/A
- EPS
- BLFS N/A
- LGIH 4.53
- Revenue
- BLFS $100,144,000.00
- LGIH $1,788,933,000.00
- Revenue This Year
- BLFS $25.65
- LGIH N/A
- Revenue Next Year
- BLFS $14.81
- LGIH $15.95
- P/E Ratio
- BLFS N/A
- LGIH $10.12
- Revenue Growth
- BLFS 87.53
- LGIH N/A
- 52 Week Low
- BLFS $19.10
- LGIH $39.70
- 52 Week High
- BLFS $29.62
- LGIH $114.56
- Technical
- Relative Strength Index (RSI)
- BLFS 33.03
- LGIH 47.37
- Support Level
- BLFS $25.49
- LGIH $45.32
- Resistance Level
- BLFS $28.21
- LGIH $49.86
- Average True Range (ATR)
- BLFS 1.00
- LGIH 2.50
- MACD
- BLFS -0.44
- LGIH 0.72
- Stochastic Oscillator
- BLFS 8.19
- LGIH 62.89
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About LGIH LGI Homes Inc.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.